Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fella Health vs Medro

Fella Health
Graded #246

Higher grade

vs+0.3999999999999986
Medro
Graded #252

Lower grade

The verdict

Fella Health takes it — 64/100 to 63.6/100, but only just.

Fella Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fella Health is a medication weight loss program built specifically for men, offering compounded GLP-1 treatments (semaglutide and tirzepatide) plus free 1:1 health coaching, board-certified clinician care,… Medro is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedro +8
42
50
Dose & formulationMedro +13
64
77
Clinical oversightFella Health +18
89
71
Labs & monitoringFella Health +11
63
52
FulfillmentMedro +17
75
92
Contract termsFella Health +22
55
33
Fella Health · left barMedro · right bar

The numbers

MetricFella HealthMedro
WeighScore64/10063.6/100
GradeCC
Scorecard rank#246#252
Semaglutide$299/mo (compounded)$199/mo (compounded)
Tirzepatide$449/mo (compounded)$299/mo (compounded)
Coverage20 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Fella Health

Graded #246 · C

Strengths

  • Specialized vertical — program designed for men, particularly 'bigger guys'
  • Free 1:1 health coaching included with the membership
  • 6-month money-back guarantee if the program doesn't work
  • Flat monthly price stays the same as your dose escalates
  • Both compounded semaglutide and tirzepatide available

Where it loses points

  • Limited to men's health vertical — not available to women
  • Available in only 20 published states (not nationwide)
  • Exact GLP-1 monthly cost not published on the public site — only an 'under $10/day' starting figure
  • Pricing transparency below industry standard for compounded GLP-1 telehealth
Medro

Graded #252 · C

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Where it loses points

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard